Boeriu M

TL;DR: It was not found that KRAS gene status had any prognostic significance, but for stage I and II patients, the mutation found on codon 13 determined a statistic significant shorter survival rate than for those with wild type.

TL;DR: A retrospective study on 74 patients treated by radical surgery found that for the patients in stage IV pTNM, the evolution was slightly better in association with a KRAS mutation than in wild type cases, and tried to appreciate the prognostic value of these mutations.

TL;DR: Due to the need for good mobilization, arterial ligations should be adjusted and modified depending on the particular vascular distribution, to maintain a sufficient blood flow in the marginal artery, in order to reach the colic sections and the straight arteries near them.

TL;DR: This classification should eliminate the confusion in terminology occurring over the last 20 years with direct implications in clinical practice by redefining local complications based on their content, existence or non-existence of the wall, the place of their appearance and their evolution over time.

TL;DR: The identification of potential predictive markers along with HP and IHC results represents a great perspective alternative in the ESCC therapy outcome and the detection of molecular type aggressiveness of the neoplastic process allows therapeutic orientation or guidance to certain therapy sequences or even to specific molecular targeted treatments.